前景研判！2025年中国生化诊断行业市场发展概况分析及投资前景预测（智研咨询）

Core Insights - The biochemical diagnosis industry in China is projected to reach a market size of 29.2 billion yuan in 2024, reflecting a year-on-year growth of 5.80% driven by increasing medical demand and advancements in diagnostic technology [2][8]. Industry Overview - Biochemical diagnosis, also known as clinical biochemical testing, is a crucial branch of in vitro diagnostics (IVD) that utilizes biochemical methods to measure specific biochemical indicators in body fluids for disease diagnosis, treatment monitoring, and health assessment [3][4]. Industry Chain - The upstream of the biochemical diagnosis industry includes biological raw materials such as enzyme preparations, antigens, antibodies, and chemical raw materials like sodium chloride and amino acids. The midstream focuses on the research and production of diagnostic reagents and instruments, while the downstream applications are found in hospitals, clinics, independent medical laboratories, health examination centers, and blood stations [6]. Market Demand Drivers - The aging population and increasing health awareness are driving the demand for medical services, with the number of hospitals in China expected to reach 38,700 in 2024, a 0.90% increase year-on-year. This growth in hospital numbers is expected to boost the demand for biochemical diagnostic products and services [8]. Technological Advancements - Recent advancements in biochemical diagnostic technology, including new enzyme detection methods and high-throughput detection platforms, have improved testing efficiency and accuracy while reducing costs, further stimulating market demand [2][8]. Relevant Policies - The Chinese government has introduced various policies to promote the healthy development of the biochemical diagnosis industry, including the "Measurement Support for New Quality Productivity Development Action Plan (2025-2030)" aimed at enhancing measurement and quality evaluation technologies in key health sectors [9][12].